UCDavis Health (2023) Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10), Diabetes & Metabolism (2019) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials, The Lancet (2019) Management of Hyperglycemia in Type 2 Diabetes, 2018
This is the dinner for nights when you are exhausted, fatigued from your medication , and need something fast
Metabolic and cardiovascular benefits GLP-1s have demonstrated significant cardiovascular benefits, particularly in patients with type 2 diabetes who are at higher risk for cardiovascular events
doi: 10.1089/jmf.2012.0069 30
Strategic synthesis: SWOT and competitive positioning K-Dense Web synthesized all upstream data into a quantitatively grounded SWOT analysis
The CAPTAIN I and CAPTAIN II trials examined its effects on moderate to severe traumatic brain injury, defined as Glasgow Coma Scale scores between 7 and 12
